The trial design included a core study phase consisting of a four-week screening period, followed by a four-week baseline phase where participants received only a placebo in a single-blind manner, and then a 24-week randomized treatment phase, where participants received either bremelanotide or placebo [1]
Herbal tea, low-sodium broths, and electrolyte drinks count toward hydration, but avoid sugary beverages, excessive caffeine, and alcoholall increase dehydration risk
The question is what comes next
Self-assembled EGCG nanoparticles with enhanced intracellular ROS scavenging for skin radioprotection
The development of new lesions resulting in enlarged macules is classified as an active form of the disease that warrants more aggressive therapy (Taieb 2012)
Zepbound (tirzepatide) On raw weight-loss numbers, tirzepatide is ahead of cagrilintide when used on its own